Cargando…
Intrathecal Injection in a Rat Model: A Potential Route to Deliver Human Wharton’s Jelly-Derived Mesenchymal Stem Cells into the Brain
Mesenchymal stem cells (MSCs) are considered as promising therapeutic agents for neurodegenerative disorders because they can reduce underlying pathology and also repair damaged tissues. Regarding the delivery of MSCs into the brain, intravenous and intra-arterial routes may be less feasible than in...
Autores principales: | Kim, Hyeongseop, Na, Duk L., Lee, Na Kyung, Kim, A Ran, Lee, Seunghoon, Jang, Hyemin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072951/ https://www.ncbi.nlm.nih.gov/pubmed/32070050 http://dx.doi.org/10.3390/ijms21041272 |
Ejemplares similares
-
Safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
por: Barczewska, Monika, et al.
Publicado: (2019) -
Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Lee, Na-Hee, et al.
Publicado: (2020) -
Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021) -
Pressure Stimuli Improve the Proliferation of Wharton’s Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions
por: Park, Sang Eon, et al.
Publicado: (2020) -
Comparative Analysis of Porcine Adipose- and Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Kim, Ga Yeon, et al.
Publicado: (2023)